Notice Number: NOT-FD-13-017

Key Dates
Release Date: June 24, 2013

Issued by
U.S. Food and Drug Administration (FDA)

Purpose

This notice is to inform potential applicants that the FDA is revising RFA-FD-13-034, “Collaborating Centers of Excellence in Regulatory Science and Innovation (U01)."

The following revisions are being made to this FOA:

Part 2. Full Text of Announcement
Section II. Award Information
Funds Available and Anticipated Number of Awards

Current Language:
FDA/OCS intends to fund an estimate of 1-2 awards, corresponding to a total of $1,400,000, contingent upon the availability of funds.

Revised Language:
FDA/OCS intends to fund an estimate of 1-2 awards, corresponding to a total not to exceed $1,400,000 in total costs (including direct and indirect costs) per budget year. The 1-2 awards will be combined, contingent upon the availability of funds. Application budgets may request funding in the amount of up to $1,400,000 per budget year for up to 3 years. Future year amounts will depend on annual appropriations and performance.

Section III. Eligibility Information

Current Language:
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Revised Language:
Foreign Institutions

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Vieda Hubbard
Grants Management Specialist
U. S. Food and Drug Administration (FDA)
Office of Acquisition and Grants Services
Rockville, MD 20857
Telephone: (301) 827-7177
Fax: (301) 827-0505
Email: Vieda.Hubbard@fda.hhs.gov